Company intelligence / Profile preview

Enzymlogic

Madrid, Community of Madrid, Spainenzymlogic.com ↗

Ownership: Private
Employees: ~30
Development stage: Commercial

Overview

Enzymlogic provides advanced kinetic profiling services using proprietary platforms KINETICfinder® and COVALfinder®, enabling pharmaceutical and biotech companies to better select promising compounds during the Hit-to-lead and Lead Optimization phases. Their technology delivers robust data on compound-target interaction kinetics, supporting improved decision-making in early drug discovery. The company has received significant recognition including EU patents, European Commission grants (€2.2M), and the EIC Accelerator Seal of Excellence.

Therapeutic areas: Rare DiseasesNeurology
Modalities: Small moleculePeptidesBiologic
Industry: Drug Discovery Services

Partnerships

Global pharmaceutical companiesBiotechs of all sizesAcademic institutionsPerha Pharmaceuticals

Beyond the preview

Go deeper on Enzymlogic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enzymlogic.

Explore the full profile